For kids with Barth syndrome, time is running out, parents say, unless the FDA acts - NBC News

The drug Elamipretide from Stealth BioTherapeutics treats an ultrarare, fatal disease called Barth syndrome. Small studies say it's safe and effective. But the FDA denied approval, leaving children with few options.